Search results
Results from the WOW.Com Content Network
Performance status In medicine ( oncology and other fields), performance status is an attempt to quantify cancer patients ' general well-being and activities of daily life. This measure is used to determine whether they can receive chemotherapy , whether dose adjustment is necessary, and as a measure for the required intensity of palliative care .
The Eastern Cooperative Oncology Group (ECOG) began in 1955 as one of the first publicly funded cooperative groups to perform multi-center clinical trials for cancer research. [1] A cooperative group in oncology constitutes a large network of private and public medical institutions developing protocols for cancer treatments.
There were four factors found to have independent prognostic relevance: age, performance status, LDH, and white blood cell count (WBC). [4] The point values are assigned as follows: 0 points: Age less than 50 years, ECOG performance status of 0–1, LDH less than 0.67 of the upper limit of normal, or WBC of less than 6,700 cells/mcl
ECOG performance status 0 (very early stage) Single nodule, < 3 cm: A: 0 A (early stage) 1–3 nodule, all < 3 cm: A or B B (intermediate stage) Multi-nodular tumor C (advanced stage) Portal invasion and extra-hepatic spread: 1 or 2 D (terminal stage) Severe liver damage: C: 3 or 4
Electrocorticography (ECoG), a type of intracranial electroencephalography (iEEG), is a type of electrophysiological monitoring that uses electrodes placed directly on the exposed surface of the brain to record electrical activity from the cerebral cortex.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
For patient eligibility to get Lutathera radioligand therapy the patient must have disease progression despite receiving somatostatin analog therapy (octreotide or lanreotide), have a locally advanced, inoperable, or metastatic well-differentiated disease, and have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2.
“So there’s a 97.5% chance you, the person reading this, cannot multitask without a decrease in your performance on the tasks.” Indeed, the cold hard facts say that multitasking is not doing ...